Regulatory
Editorial: Will the Market Competition Urge GMP Compliance?
November 11th 2011It’s always a pleasure when FDA provides its GMP regulatory compliance updates. I’ve heard Brad Williams, manager of FDA’s Division of Dietary Supplement Programs, speak several times at industry events and, most recently, at October’s SupplySide West show in Las Vegas. Hearing firsthand from FDA how our industry is doing in terms of GMP compliance provides a good idea of where we are-and how far we have to go.
EU Health Claims Process Will Increase Consumer Confusion, Decrease Choice, EHPM Says
November 8th 2011“With a prediction of a 25% drop in the market for substances other than vitamins and minerals, the regulation will fail in its main objectives and severely damage the economic profitability of the sector.”
CRN Sends FDA More Comments on Revised Phytosterol Rule
October 31st 2011Moreover, the association argues, FDA’s proposed enforcement deadline of February 21, 2012, is “untenable” for supplement marketers, many of whom CRN contends would find it difficult to replace or reformulate current products in time.
Jarrow Formulas Sends Extensive Freedom of Information Request to FDA over NDI Draft Guidance
September 19th 2011Dietary supplements manufacturer Jarrow Formulas says that it has sent FDA a comprehensive Freedom of Information Act (FOIA) request relating to FDA’s recently issued new dietary ingredient (NDI) draft guidance.